本页面由Tiger Trade Technology Pte. Ltd.提供服务

Benitec Biopharma Limited

12.35
+0.85007.39%
盘后12.590.2400+1.94%19:51 EST
成交量:14.41万
成交额:175.00万
市值:4.18亿
市盈率:-11.70
高:12.50
开:11.50
低:10.99
收:11.50
52周最高:17.15
52周最低:9.70
股本:3,386.22万
流通股本:2,085.08万
量比:0.52
换手率:0.69%
股息:- -
股息率:- -
每股收益(TTM):-1.0556
每股收益(LYR):-1.0472
净资产收益率:-53.01%
总资产收益率:-34.72%
市净率:4.47
市盈率(LYR):-11.79

数据加载中...

2022/09/23

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/09/16

重要事件披露

8-K - Current report
2022/09/12

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/09/09

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/09/08

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/08

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/07

重要事件披露

8-K - Current report
2022/09/02

重要事件披露

8-K - Current report
2022/09/02

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/08/11

SEC问询函

CORRESP [Cover] - Correspondence
2022/08/10

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/08/08

SEC问询函

CORRESP [Cover] - Correspondence
2022/08/08

SEC问询函

CORRESP [Cover] - Correspondence
2022/08/08

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/07/29

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2022/05/16

重要事件披露

8-K - Current report
2022/05/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/02/14

重要事件披露

8-K - Current report
2022/02/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals